NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
Clinical trial NCT05189925 · RECRUITING
Trial details
- NCT number
- NCT05189925
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-22
- Primary completion
- 2027-07-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.